跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 64,638 条关于
“kallikrein 2”
全部
64,638
临床试验
42,039
药物
7,322
机构
1,389
资讯
13,888
2个月前
Masked T-Cell Engagers and Pasritamig Raise New Hope for Advanced Prostate Cancer Immunotherapy
2年前
J&J Highlights Solid Tumor Advances at WCLC and ESMO 2024
去年
Johnson & Johnson's Pasritamig Shows Promising Anti-Tumor Activity in First-in-Human Prostate Cancer Trial
去年
Juri Biosciences Secures Global Rights to KLK2-Targeted T-Cell Engager for Metastatic Prostate Cancer in $210M Deal
去年
Triveni Bio Initiates First-in-Human Trial of TRIV-509 for Atopic Dermatitis, Targeting Novel Kallikrein Pathway
去年
Rezolute's Oral Plasma Kallikrein Inhibitor RZ-402 Shows Promise in Phase IIa Trial for Diabetic Macular Edema
去年
NTLA-2002 Shows Promise as Functional Cure for Hereditary Angioedema in Phase 2 Trial
7个月前
ADARx Pharmaceuticals to Present Phase 1/2 Data for Onvuzosiran siRNA Therapy at AAAAI 2026 Meeting
去年
CRISPR Therapy NTLA-2002 Shows Promise in Hereditary Angioedema Treatment
11个月前
ADARx Pharmaceuticals Initiates Phase 3 Trial for ADX-324 in Hereditary Angioedema, Receives FDA Orphan Drug Designation
第 1 页,共 1389 页
上一页
下一页